| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.44 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |